Transforming growth factor-β1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells

Journal of Cellular Biochemistry

Volumn 108, Issue 2, 2009, Pages 408-414

  Kwok, Sukyee ^a   Rittling, Susan R ^b   Partridge, Nicola C ^a   Benson, Chellakkan S ^c   Thiyagaraj, Mayuranathan ^c   Srinivasan, Narasimhan ^c   Selvamurugan, Nagarajan ^c  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b FORSYTH INSTITUTE   (United States)

^c UNIVERSITY OF MADRAS   (India)

Author keywords

ATF 3; Cyclin A1; MMP 13; TGF B

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CELL DNA; COLLAGENASE 3; CYCLIN A1; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA INTERFERENCE;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CYCLIN A1; CYCLINS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MATRIX METALLOPROTEINASE 13; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; TISSUE ARRAY ANALYSIS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70349260175     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22267     Document Type: Article

References (33)

1. Allan AL, Albanese C, Pestell RG, LaMarre J. 2001. Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes. J Biol Chem 276:27272-27280. (Pubitemid 37410640)
2. Anbazhagan R, Bornman DM, Johnston JC, Westra WH, Gabrielson E. 1999. The S387Y mutation of the transforming growth factor-β receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma. Cancer Res 59:3363-3364. (Pubitemid 29334492)
3. Barnes GL, Hebert KE, Kamal M, Javed A, Einhorn TA, Lian JB, Stein GS, Gerstenfeld LC. 2004. Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease. Cancer Res 64:4506-4513. (Pubitemid 38856922)
4. Chen Y, Rittling SR. 2003. Novel murine mammary epithelial cell lines that form osteolytic bone metastases: Effect of strain background on tumor homing. Clin Exp Metas 20:111-120. (Pubitemid 36403276)
5. Chen BP, Liang G, Whelan J, Hai T. 1994. ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. J Biol Chem 269:15812-15819. (Pubitemid 2090807)
6. Chen CR, Kang Y, Massague J. 2001. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. Proc Natl Acad Sci USA 98:992-999. (Pubitemid 32121175)
7. Eferl R, Wagner EF. 2003. AP-1: A double-edged sword in tumorigenesis. Nat Rev Cancer 3:859-868.
8. Engle SJ, Hoying JB, Boivin GP, Ormsby I, Gartside PS, Doetschman T. 1999. Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res 59:3379-3386. (Pubitemid 29334496)
9. Fawcett TW, Martindale JL, Guyton KZ, Hai T, Holbrook NJ. 1999. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element- binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem J 339:135-141. (Pubitemid 29179300)
10. Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U. 1999. ATF3 and stress responses. Gene Expr 7:321-335.
11. Hsu JC, Bravo R, Taub R. 1992. Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol 12:4654-4665.
12. Hsu JC, Cressman DE, Taub R. 1993. Promoter-specific trans-activation and inhibition mediated by JunB. Cancer Res 53:3789-3794. (Pubitemid 23252044)
13. Javed A, Barnes GL, Pratap J, Antkowiak T, Gerstenfeld LC, van Wijnen AJ, Stein JL, Lian JB, Stein GS. 2005. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci USA 102:1454-1459. (Pubitemid 40209191)
14. Kang Y, Chen CR, Massague J. 2003. A self-enabling TGF β response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 11:915-926. (Pubitemid 36566314)
15. Linardopoulos S, Gonos ES, Spandidos DA. 1993. Abnormalities of retinoblastoma gene structure in human lung tumors. Cancer Lett 71:67-74. (Pubitemid 23251976)
16. Massague J. 2000. How cells read TGF-β signals. Nat Rev Mol Cell Biol 1:169-178.
17. Massague J, Wotton D. 2000. Transcriptional control by the TGF-/Smad signaling system. EMBO J 19:1745-1754. (Pubitemid 30204386)
18. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. 1996. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10:2462-2477. (Pubitemid 26341881)
19. Piek E, Roberts AB. 2001. Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis. Adv Cancer Res 83:1-54. (Pubitemid 32959260)
20. Piek E, Heldin CH, Ten Dijke P. 1999. Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J 13:2105-2124.
21. Pratap J, Javed A, Languino LR, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2005. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol 25:8581-8591. (Pubitemid 41369178)
22. Pratap J, Lian JB, Javed A, Barnes GL, van Wijnen AJ, Stein JL, Stein GS. 2006. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev 25:589-600. (Pubitemid 46071865)
23. Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja TP. 1991. Oncogenic germline mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature 353:83-86. (Pubitemid 21912463)
24. Selvamurugan N, Chou WY, Pearman AT, Pulumati MR, Partridge NC. 1998. Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. J Biol Chem 273:10647-10657. (Pubitemid 28227678)
25. Selvamurugan N, Fung Z, Partridge NC. 2002. Transcriptional activation of collagenase-3 by transforming growth factor-beta1 is via MAPK and Smad pathways in human breast cancer cells. FEBS Lett 532:31-35. (Pubitemid 35375862)
26. Selvamurugan N, Kwok S, Partridge NC. 2004. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-1-stimulated collagenase-3 expression in human breast cancer cells. J Biol Chem 279:27764-27773. (Pubitemid 38812618)
27. Tomita S, Deguchi S, Miyaguni T, Muto Y, Tamamoto T, Toda T. 1999. Analyses of microsatellite instability and the transforming growth factor-β receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features. Br Cancer Res Treat 53:33-39. (Pubitemid 29123617)
28. Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, Carter D, Glazer PM, Hurst HC, Haffty BG, Williams T. 1998. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res 58:5466-5472. (Pubitemid 28551131)
29. Welch DR, Fabra A, Nakajima M. 1990. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87:7678-7682. (Pubitemid 20341780)
30. Wolfgang CD, Chen BP, Martindale JL, Holbrook NJ, Hai T. 1997. gadd153/Chop10, a potential target gene of the transcriptional repressor ATF3. Mol Cell Biol 17:6700-6707. (Pubitemid 27451217)
31. Wolfgang CD, Liang G, Okamoto Y, Allen AE, Hai T. 2000. Transcriptional autorepression of the stress-inducible gene ATF3. J Biol Chem 275:16865-16870. (Pubitemid 30398922)
32. Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, Massague J, Mundy GR, Guise TA. 1999. TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103:197-206. (Pubitemid 29053137)
33. Yoshizumi M, Hsieh CM, Zhou F, Tsai JC, Patterson C, Perrella MA, Lee ME. 1995. The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells. Mol Cell Biol 15:3266-3272.